BioNTech SE - Depositary Receipt (Common Stock)
US ˙ NasdaqGS ˙ US09075V1026

SecurityBNTX / BioNTech SE - Depositary Receipt (Common Stock)
InstitutionCenterBook Partners LP
Latest Disclosed Ownership171,166 shares
Latest Disclosed Value $ 15,213,234
CenterBook Partners LP reports 27.53% decrease in ownership of BNTX / BioNTech SE - Depositary Receipt (Common Stock)

On May 5, 2026 - CenterBook Partners LP filed a 13F-HR form disclosing ownership of 171,166 shares of BioNTech SE - Depositary Receipt (Common Stock) (US:BNTX) valued at $15,213,234 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 236,175 shares of BioNTech SE - Depositary Receipt (Common Stock). This represents a change in shares of -27.53% during the quarter. The current value of the position is $15,076,301 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F BIONTECH SE SPONSORED ADS 09075V102 171,166 -65,009 -27.53 15,213 -32.34 0.8174
2026-02-11 2025-12-31 13F BIONTECH SE SPONSORED ADS 09075V102 236,175 22,484
2025-11-07 2025-09-30 13F BIONTECH SE SPONSORED ADS 09075V102 185,491 -30,453 -14.10 18,293 -20.43 0.9039
2025-08-12 2025-06-30 13F BIONTECH SE SPONSORED ADS 09075V102 215,944 106,527 97.36 22,992 130.76 1.2773
2025-05-09 2025-03-31 13F BIONTECH SE SPONSORED ADS 09075V102 109,417 -84,701 -43.63 9,964 -54.96 0.6347
2025-02-13 2024-12-31 13F BIONTECH SE SPONSORED ADS 09075V102 194,118 74,656 62.49 22,120 55.90 1.3214
2024-11-14 2024-09-30 13F BIONTECH SE SPONSORED ADS 09075V102 119,462 -86,772 -42.07 14,189 -14.39 0.8721
2024-08-12 2024-06-30 13F BIONTECH SE SPONSORED ADS 09075V102 206,234 206,234 16,573 1.0299
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.